Progress of prophylactic cranial irradiation in treatment of non-small cell lung cancer

VernacularTitle:预防性全脑照射治疗非小细胞肺癌的研究进展
Author: Meng LI ¹ ; Xiang WANG ; Taifang WANG ; Ping WEN ; Chunli WU ; Yue YU ; Yueling ZHOU
Author Information

1. 中国医科大学附属第四医院放疗科，沈阳　110000
Keywords: Carcinoma, non-small-cell lung; Prophylactic cranial irradiation; Adverse reactions; Disease-free survival
From: Cancer Research and Clinic 2022;34(1):73-76
CountryChina
Language:Chinese
Abstract: The incidence of brain metastases in patients with non-small cell lung cancer (NSCLC) has increased as a result of improved local control rate and survival rate. Prophylactic cranial irradiation (PCI) has been proven to reduce the incidence of brain metastases and improve survival rate in patients with NSCLC. However, the value of PCI for NSCLC is still controversial. This paper reviews the progress of the efficacy and adverse reactions after PCI treatment for patients with NSCLC.